Nā Hoʻololi KRAS 8

Wehewehe Pōkole:

Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative in vitro o 8 mau mutations i nā codons 12 a me 13 o ka gene K-ras i loko o ka DNA i unuhi ʻia mai nā ʻāpana pathological i hoʻokomo ʻia me ka paraffin kanaka.


Nā kikoʻī huahana

Nā Lepili Huahana

Inoa huahana

Pahu ʻIke Hoʻololi HWTS-TM014-KRAS 8 (Fluorescence PCR)

Palapala hōʻoia

CE/TFDA/Myanmar FDA

ʻAlapia

Ua loaʻa nā hoʻololi kiko i loko o ka gene KRAS i loko o kekahi mau ʻano puʻupuʻu kanaka, ma kahi o 17% ~ 25% ka nui o ka hoʻololi ʻana i loko o ka puʻupuʻu, 15% ~ 30% ka nui o ka hoʻololi ʻana i nā maʻi maʻi kanesa māmā, 20% ~ 50% ka nui o ka hoʻololi ʻana i nā maʻi kanesa colorectal. No ka mea, aia ka protein P21 i hoʻopili ʻia e ka gene K-ras ma lalo o ke ala hōʻailona EGFR, ma hope o ka hoʻololi ʻana o ka gene K-ras, hoʻāla mau ʻia ke ala hōʻailona ma lalo a ʻaʻole i hoʻopilikia ʻia e nā lāʻau lapaʻau i kuhikuhi ʻia ma luna ma EGFR, e hopena ana i ka hoʻonui mau ʻana o nā cell malignant. ʻO nā hoʻololi ʻana i loko o ka gene K-ras e hāʻawi pinepine i ke kūʻē ʻana i nā mea hoʻopaʻa EGFR tyrosine kinase i nā maʻi maʻi kanesa māmā a me ke kūʻē ʻana i nā lāʻau anti-EGFR antibody i nā maʻi kanesa colorectal. I ka makahiki 2008, ua hoʻopuka ka National Comprehensive Cancer Network (NCCN) i kahi alakaʻi hana lapaʻau no ka maʻi kanesa colorectal, kahi i kuhikuhi ai ʻo nā wahi hoʻololi e hoʻāla ai iā K-ras aia ma nā codons 12 a me 13 o exon 2, a ua ʻōlelo ʻia e hiki ke hoʻāʻo ʻia nā maʻi āpau me ka maʻi kanesa colorectal metastatic holomua no ka hoʻololi K-ras ma mua o ka mālama ʻana. No laila, he mea nui ka ʻike wikiwiki a pololei ʻana i ka hoʻololi ʻana o ka gene K-ras i ke alakaʻi lāʻau lapaʻau. Hoʻohana kēia pahu i ka DNA ma ke ʻano he laʻana ʻike e hāʻawi i ka loiloi qualitative o ke kūlana mutation, hiki ke kōkua i nā kauka i ka nānā ʻana i ke kanesa colorectal, ke kanesa māmā a me nā maʻi puʻupuʻu ʻē aʻe e pōmaikaʻi ana mai nā lāʻau lapaʻau i kuhikuhi ʻia. ʻO nā hopena hoʻāʻo o ka pahu no ka ʻike lapaʻau wale nō a ʻaʻole pono e hoʻohana ʻia ma ke ʻano he kumu hoʻokahi no ka mālama pilikino ʻana i nā maʻi. Pono nā kauka e hana i nā hoʻoholo piha ma nā hopena hoʻāʻo ma muli o nā mea e like me ke kūlana o ka mea maʻi, nā hōʻailona lāʻau, ka pane lapaʻau a me nā hōʻailona hoʻāʻo hale hana ʻē aʻe.

Nā Palena ʻenehana

Ka Waihona Wai: ≤-18℃ I ka pōʻeleʻele; Lyophilized: ≤30℃ I ka pōʻeleʻele
Ola papa Wai: 9 mahina; Lyophilized: 12 mahina
ʻAno Laʻana ʻO ka ʻiʻo pathological i hoʻokomo ʻia i ka paraffin a i ʻole ka ʻāpana he mau cell tumorous
CV ≤5.0%
LoD Hiki i ka K-ras Reaction Buffer A a me ka K-ras Reaction Buffer B ke ʻike paʻa i ka 1% mutation rate ma lalo o 3ng/μL wild-type background
Nā Mea Hana Pili Nā ʻōnaehana Biosystems i hoʻopili ʻia 7500 Nā ʻōnaehana PCR Manawa Maoli

Nā ʻōnaehana Biosystems i hoʻopili ʻia 7300 Nā ʻōnaehana PCR Manawa Maoli

Nā ʻōnaehana PCR Manawa Maoli QuantStudio®5

ʻŌnaehana PCR Manawa Maoli LightCycler® 480

ʻŌnaehana PCR Manawa Maoli BioRad CFX96

Kahe Hana

Manaʻo ʻia e hoʻohana i ka QIAGEN's QIAamp DNA FFPE Tissue Kit (56404) a me ka Paraffin-embedded Tissue DNA Rapid Extraction Kit (DP330) i hana ʻia e Tiangen Biotech (Beijing) Co., Ltd.


  • Ma mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou